Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

? Special Offer?Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

? New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Actoxumab Biosimilar – Anti-toxin A mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1, kappa

200.00

100ug +200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Actoxumab Biosimilar - Anti-toxin A mAb - Research Grade

Product name Actoxumab Biosimilar - Anti-toxin A mAb - Research Grade
Source CAS 1245634-25-6
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Actoxumab,CDA 1,MBL-CDA1,MDX-066,MK-3415A (combination of actoxumab and bezlotoxumab),toxin A,anti-toxin A
Reference PX-TA1285
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Actoxumab Biosimilar - Anti-toxin A mAb - Research Grade
Source CAS 1245634-25-6
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Actoxumab,CDA 1,MBL-CDA1,MDX-066,MK-3415A (combination of actoxumab and bezlotoxumab),toxin A,anti-toxin A
Reference PX-TA1285
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-toxin A[Clostridium difficile] (Actoxumab) Monoclonal Antibody

Actoxumab has been investigated for the treatment of Clostridium Difficile Infections.

There are no reviews yet.

Be the first to review “Actoxumab Biosimilar – Anti-toxin A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products